These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18378677)

  • 1. Noonan syndrome-associated SHP-2/Ptpn11 mutants enhance SIRPalpha and PZR tyrosyl phosphorylation and promote adhesion-mediated ERK activation.
    Eminaga S; Bennett AM
    J Biol Chem; 2008 May; 283(22):15328-38. PubMed ID: 18378677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PZR coordinates Shp2 Noonan and LEOPARD syndrome signaling in zebrafish and mice.
    Paardekooper Overman J; Yi JS; Bonetti M; Soulsby M; Preisinger C; Stokes MP; Hui L; Silva JC; Overvoorde J; Giansanti P; Heck AJ; Kontaridis MI; den Hertog J; Bennett AM
    Mol Cell Biol; 2014 Aug; 34(15):2874-89. PubMed ID: 24865967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosyl phosphorylation of PZR promotes hypertrophic cardiomyopathy in PTPN11-associated Noonan syndrome with multiple lentigines.
    Yi JS; Perla S; Enyenihi L; Bennett AM
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32584792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose dasatinib rescues cardiac function in Noonan syndrome.
    Yi JS; Huang Y; Kwaczala AT; Kuo IY; Ehrlich BE; Campbell SG; Giordano FJ; Bennett AM
    JCI Insight; 2016 Dec; 1(20):e90220. PubMed ID: 27942593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature.
    De Rocca Serra-Nédélec A; Edouard T; Tréguer K; Tajan M; Araki T; Dance M; Mus M; Montagner A; Tauber M; Salles JP; Valet P; Neel BG; Raynal P; Yart A
    Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4257-62. PubMed ID: 22371576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs.
    Zhao R; Zhao ZJ
    J Biol Chem; 2000 Feb; 275(8):5453-9. PubMed ID: 10681522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association.
    Stofega MR; Wang H; Ullrich A; Carter-Su C
    J Biol Chem; 1998 Mar; 273(12):7112-7. PubMed ID: 9507023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling.
    Uhlén P; Burch PM; Zito CI; Estrada M; Ehrlich BE; Bennett AM
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2160-5. PubMed ID: 16461457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia.
    Niihori T; Aoki Y; Ohashi H; Kurosawa K; Kondoh T; Ishikiriyama S; Kawame H; Kamasaki H; Yamanaka T; Takada F; Nishio K; Sakurai M; Tamai H; Nagashima T; Suzuki Y; Kure S; Fujii K; Imaizumi M; Matsubara Y
    J Hum Genet; 2005; 50(4):192-202. PubMed ID: 15834506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noonan syndrome/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis.
    Wang S; Yu WM; Zhang W; McCrae KR; Neel BG; Qu CK
    J Biol Chem; 2009 Jan; 284(2):913-20. PubMed ID: 19008228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2.
    Oh ES; Gu H; Saxton TM; Timms JF; Hausdorff S; Frevert EU; Kahn BB; Pawson T; Neel BG; Thomas SM
    Mol Cell Biol; 1999 Apr; 19(4):3205-15. PubMed ID: 10082587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine phosphatase SHP-2 regulates IL-1 signaling in fibroblasts through focal adhesions.
    Herrera Abreu MT; Wang Q; Vachon E; Suzuki T; Chow CW; Wang Y; Hong O; Villar J; McCulloch CA; Downey GP
    J Cell Physiol; 2006 Apr; 207(1):132-43. PubMed ID: 16250012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migration.
    Zannettino AC; Roubelakis M; Welldon KJ; Jackson DE; Simmons PJ; Bendall LJ; Henniker A; Harrison KL; Niutta S; Bradstock KF; Watt SM
    Biochem J; 2003 Mar; 370(Pt 2):537-49. PubMed ID: 12410637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation.
    Liénard H; Bruhns P; Malbec O; Fridman WH; Daëron M
    J Biol Chem; 1999 Nov; 274(45):32493-9. PubMed ID: 10542295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P
    Roubelakis MG; Tsaknakis G; Lyu FJ; Trohatou O; Zannettino ACW; Watt SM
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations.
    Oishi K; Gaengel K; Krishnamoorthy S; Kamiya K; Kim IK; Ying H; Weber U; Perkins LA; Tartaglia M; Mlodzik M; Pick L; Gelb BD
    Hum Mol Genet; 2006 Feb; 15(4):543-53. PubMed ID: 16399795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation and localization of protein-zero related (PZR) in cultured endothelial cells.
    Kusano K; Thomas TN; Fujiwara K
    Endothelium; 2008; 15(3):127-36. PubMed ID: 18568953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for SHPS-1/SIRPalpha in Concanavalin A-dependent production of MMP-9.
    Ruhul Amin AR; Uddin Biswas MH; Senga T; Feng GS; Kannagi R; Agarwal ML; Hamaguchi M
    Genes Cells; 2007 Sep; 12(9):1023-33. PubMed ID: 17825046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ability of protein tyrosine phosphatase SHP-1 to suppress NFkappaB can be inhibited by dominant negative mutant of SIRPalpha.
    Neznanov N; Neznanova L; Kondratov RV; O'Rourke DM; Ullrich A; Gudkov AV
    DNA Cell Biol; 2004 Mar; 23(3):175-82. PubMed ID: 15068587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.